Cargando…
Effects of the Demethylating Agent, 5-Azacytidine, on Expression of the Kallikrein-Kinin Genes in Carcinoma Cells of the Lung and Pleura
Tissue kallikrein (KLK1) and plasma kallikrein (KLKB1) may regulate the growth and proliferation of tumours of the lung and pleura, through the generation of kinin peptides that signal through the kinin B(1) (BDKRB1) and B(2) (BDKRB2) receptors. The development and progression of cancer results from...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166727/ https://www.ncbi.nlm.nih.gov/pubmed/21904690 http://dx.doi.org/10.4061/2011/167046 |
_version_ | 1782211175485800448 |
---|---|
author | Wong, Joshua Sia, Yee Yen Misso, Neil L. Aggarwal, Shashi Ng, Angeline Bhoola, Kanti D. |
author_facet | Wong, Joshua Sia, Yee Yen Misso, Neil L. Aggarwal, Shashi Ng, Angeline Bhoola, Kanti D. |
author_sort | Wong, Joshua |
collection | PubMed |
description | Tissue kallikrein (KLK1) and plasma kallikrein (KLKB1) may regulate the growth and proliferation of tumours of the lung and pleura, through the generation of kinin peptides that signal through the kinin B(1) (BDKRB1) and B(2) (BDKRB2) receptors. The development and progression of cancer results from genetic mutations, as well as epigenetic changes that include methylation of DNA at CpG islands. The aim of this study was to assess whether expression of the kallikrein-kinin genes in lung cancer and mesothelioma cells is regulated by DNA methylation. Quantitative reverse transcriptase-PCR and immunocytochemistry showed differences in the basal expression of the kallikrein-kinin genes and proteins in lung carcinoma and mesothelioma cells, compared with non-malignant lung epithelial and mesothelial cells, respectively. Following treatment with the demethylating agent, 5-azacytidine (5-AZA), KLKB1 mRNA expression was consistently increased in both lung carcinoma and mesothelioma cells, whereas KLK1, BDKRB1 and BDKRB2 mRNA expression was decreased or unchanged. Increased expression of KLKB1 after 5-AZA treatment suggests it may function as a tumour suppressor gene in cancers of the lung and pleura. Studies on DNA methylation of the kallikrein-kinin genes will enhance understanding of their role in carcinogenesis and provide insights into the importance of kallikreins as tumour biomarkers. |
format | Online Article Text |
id | pubmed-3166727 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | SAGE-Hindawi Access to Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-31667272011-09-08 Effects of the Demethylating Agent, 5-Azacytidine, on Expression of the Kallikrein-Kinin Genes in Carcinoma Cells of the Lung and Pleura Wong, Joshua Sia, Yee Yen Misso, Neil L. Aggarwal, Shashi Ng, Angeline Bhoola, Kanti D. Patholog Res Int Research Article Tissue kallikrein (KLK1) and plasma kallikrein (KLKB1) may regulate the growth and proliferation of tumours of the lung and pleura, through the generation of kinin peptides that signal through the kinin B(1) (BDKRB1) and B(2) (BDKRB2) receptors. The development and progression of cancer results from genetic mutations, as well as epigenetic changes that include methylation of DNA at CpG islands. The aim of this study was to assess whether expression of the kallikrein-kinin genes in lung cancer and mesothelioma cells is regulated by DNA methylation. Quantitative reverse transcriptase-PCR and immunocytochemistry showed differences in the basal expression of the kallikrein-kinin genes and proteins in lung carcinoma and mesothelioma cells, compared with non-malignant lung epithelial and mesothelial cells, respectively. Following treatment with the demethylating agent, 5-azacytidine (5-AZA), KLKB1 mRNA expression was consistently increased in both lung carcinoma and mesothelioma cells, whereas KLK1, BDKRB1 and BDKRB2 mRNA expression was decreased or unchanged. Increased expression of KLKB1 after 5-AZA treatment suggests it may function as a tumour suppressor gene in cancers of the lung and pleura. Studies on DNA methylation of the kallikrein-kinin genes will enhance understanding of their role in carcinogenesis and provide insights into the importance of kallikreins as tumour biomarkers. SAGE-Hindawi Access to Research 2011 2011-09-04 /pmc/articles/PMC3166727/ /pubmed/21904690 http://dx.doi.org/10.4061/2011/167046 Text en Copyright © 2011 Joshua Wong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wong, Joshua Sia, Yee Yen Misso, Neil L. Aggarwal, Shashi Ng, Angeline Bhoola, Kanti D. Effects of the Demethylating Agent, 5-Azacytidine, on Expression of the Kallikrein-Kinin Genes in Carcinoma Cells of the Lung and Pleura |
title | Effects of the Demethylating Agent, 5-Azacytidine, on Expression of the Kallikrein-Kinin Genes in Carcinoma Cells of the Lung and Pleura |
title_full | Effects of the Demethylating Agent, 5-Azacytidine, on Expression of the Kallikrein-Kinin Genes in Carcinoma Cells of the Lung and Pleura |
title_fullStr | Effects of the Demethylating Agent, 5-Azacytidine, on Expression of the Kallikrein-Kinin Genes in Carcinoma Cells of the Lung and Pleura |
title_full_unstemmed | Effects of the Demethylating Agent, 5-Azacytidine, on Expression of the Kallikrein-Kinin Genes in Carcinoma Cells of the Lung and Pleura |
title_short | Effects of the Demethylating Agent, 5-Azacytidine, on Expression of the Kallikrein-Kinin Genes in Carcinoma Cells of the Lung and Pleura |
title_sort | effects of the demethylating agent, 5-azacytidine, on expression of the kallikrein-kinin genes in carcinoma cells of the lung and pleura |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166727/ https://www.ncbi.nlm.nih.gov/pubmed/21904690 http://dx.doi.org/10.4061/2011/167046 |
work_keys_str_mv | AT wongjoshua effectsofthedemethylatingagent5azacytidineonexpressionofthekallikreinkiningenesincarcinomacellsofthelungandpleura AT siayeeyen effectsofthedemethylatingagent5azacytidineonexpressionofthekallikreinkiningenesincarcinomacellsofthelungandpleura AT missoneill effectsofthedemethylatingagent5azacytidineonexpressionofthekallikreinkiningenesincarcinomacellsofthelungandpleura AT aggarwalshashi effectsofthedemethylatingagent5azacytidineonexpressionofthekallikreinkiningenesincarcinomacellsofthelungandpleura AT ngangeline effectsofthedemethylatingagent5azacytidineonexpressionofthekallikreinkiningenesincarcinomacellsofthelungandpleura AT bhoolakantid effectsofthedemethylatingagent5azacytidineonexpressionofthekallikreinkiningenesincarcinomacellsofthelungandpleura |